Overview
- The Minnesota House passed a bipartisan psilocybin therapy pilot as an amendment to SF 4612 after a state task force urged a cautious rollout.
- The pilot would enroll up to 1,000 adults 21 and older who have conditions such as PTSD, chronic pain or substance use disorder after medical screening.
- Patients could take psilocybin only during in-person sessions with a registered facilitator, and the Office of Cannabis Management would oversee and evaluate the program.
- The House and Senate must reconcile differences in a conference committee before the May 18 end of session, after which the bill would go to Gov. Tim Walz.
- If enacted, Minnesota would join Colorado, New Mexico and Oregon in allowing supervised psilocybin therapy.